Welcome to Top Store

Cart

Cart

Your Cart is Empty

Back To Shop

TAFINLAR (DABRAFENIB)

$8,400.00 Ex. VAT

Compare

TAFINLAR (DABRAFENIB)
PRODUCT: TAFINLAR (DABRAFENIB) CAPSULES, FOR ORAL USE.
INITIAL U.S. APPROVAL: 2015
STRENGTH: CAPSULES: 50 MG, 75 MG
COMPANY: GLAXOSMITHKLINE
INDICATION: METASTATIC MELANOMA WITH BRAF V600E MUTATION. NON-SMALL CELL LUNG CANCER (NSCLC).

PHARMACEUTICALRAWSTEROIDS CAN FACILITATE PATIENTS AND PHYSICIANS ACCESS TO COMMERCIALLY APPROVED MEDICINES, “TAFINLAR (DABRAFENIB) ” TO ALL LOCATIONS IN THE WORLD AND IN INDIA AFTER FULFILLING THE LEGAL REQUIREMENT (IF APPLICABLE). TAFINLAR (DABRAFENIB) IS A PRESCRIPTION DRUG AND SHOULD BE USED UNDER PROPER MEDICAL GUIDANCE AND ADVICE. THE ORDER WILL BE CONFIRMED ONLY AFTER THE RECEIPT OF VALID PRESCRIPTION OF DOCTOR AND IMPORT PERMIT IF APPLICABLE.

Reviews

There are no reviews yet.

Be the first to review “TAFINLAR (DABRAFENIB)”

Your email address will not be published. Required fields are marked *

Category:

Cart

Cart

Your Cart is Empty

Back To Shop